On a scale of cardiac density that begins with Blondie’s heart of glass and ends with the Rolling Stones’ heart of stone, Houston-based startup Bivacor’s...
ReCor Medical‘s renal denervation significantly reduced blood pressure among people with drug-resistant hypertension, according to a new study reported at the American College of...
Virtual reality has shown the potential to help patients deal with pain and anxiety during difficult procedures and clinical trials. Clinical Trials Arena speaks...
RenovaCare, Inc., announced that its Investigational Device Exemption (IDE) application has been granted full approval by the U.S. Food and Drug Administration (FDA). This...
NanoVibronix, Inc., a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that...
Innocoll Biotherapeutics announced that it initiated two Phase 3 trials to support a label expansion for its collagen drug-device implant.
Athlone, Ireland-based Innocoll’s trials are seeking...
International oncology company, Novocure, has announced an update regarding its phase 3 pivotal LUNAR trial of Tumor Treating Fields (TTFields) in stage 4 non-small cell...
Further participation from existing investors raised additional €7 million
Additional capital to fund initiation of the first clinical trial of eAUS in patients suffering from...
